Multiple Myeloma Rounds ®

Multiple Myeloma Rounds ®

  We are excited to announce the formation of the Multiple Myeloma Rounds® !

                Please Join us at one of these Free CME/CE Accredited Dinner Programs in your area!

In 2016, Dr. Agne Paner and her colleagues at several institutions in the Chicago area joined together to form the Chicago Multiple Myeloma Rounds Committee. Their collaborative effort led to the implementation of four Multiple Myeloma Rounds programs that were held in the Chicago area in 2016.

As a result of the success of the Chicago Multiple Myeloma Rounds, the Committee decided to expand the program to other multiple myeloma communities around the country.  

We are pleased that the Multiple Myeloma Rounds program has now grown to include a Committee of 36 multiple myeloma specialists from 24 different institutions who will be implementing the Multiple Myeloma Rounds program in 5 cities across the country!

This program will continue to provide a forum for local healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their multiple myeloma patients.  

The Multiple Myeloma Rounds provides an opportunity for participants to exchange information, network with their colleagues, share best practices and learn the latest information on new therapies and advances in the management of multiple myeloma through interactive case studies presented by experts in the local area.

Please join us at one of the upcoming events! 

The Multiple Myeloma Rounds Program Chairs and Committee Members

Chicago Multiple Myeloma Rounds Founding Chair and CME Course Director: 
Agne Paner, MD Rush University

Chicago Multiple Myeloma Rounds Regional Chairpersons 
(A complete list of all Committee Members can be found on tab at top of page)

Ajay K. Nooka, MD, MPH, FACP Winship Cancer Institute Emory University
Agne Paner, MD Rush University
Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD Moffitt Cancer Center
 Ola Landgren, MD and Neha S. Korde, MD Memorial Sloan Kettering Cancer Center
William Bensinger, MD Swedish Cancer Institute

 logo colors 04 text at bottomsmall           
12 252 LRF Final Logo             Plexus logo 1.28           Rush Logo MasterBrndTransparent                                      


Accreditation Information: 

In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.


Rush University Medical Center designates this Live Activity for a maximum of two (2) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 


Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for two (2) Continuing Education credits. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses. 


This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.

There is no fee for participating in this activity.

Educational Objectives:

1.  Distinguish among the biologic and molecular mechanisms involved in the pathology of MM as it relates to therapeutic targets and treatment selection

2.  Appraise conventional, newly approved, and emerging therapies thathave the potential to enhance clinical outcomes

3.  Identify disease- and therapy-associated adverse events and utilize evidence-based management strategies

4.  Devise optimal evidence-based strategies for individualized treatment

5. Identify limitations and controversies in the standard of care treatment in MM, and how these pertain to individual patient management

Multiple Myeloma Rounds®: is supported by an educational grant from AbbVie Inc., Amgen, Celgene Corporation, Incyte Corporation, Janssen Biotech, Inc., and Merck

Date: Wednesday, October 3, 2018
Time: 6:00pm-8:30pm
Location: Courtyard Atlanta Decatur Downtown/Emory
                 130 Clairemont Ave, Decatur, GA 30030


Atlanta Multiple Myeloma Rounds Committee:

Emory University:
     Ajay Nooka, MD, MPH, FACP (Program Chair)

Cancer Treatment Centers of America:  
     Mary Ninan, MD

Georgia Cancer Specialists:  
     Kathleen Lambert, MD
     Lynn Zemsky, MD

Northwest Georgia Oncology Centers: 
    Michael B. Andrews, MD

Piedmont Cancer Institute:  
     Jonathan Bender, MD

Suburban Hematology-Oncology Associates: 
 Praveen Sivakumaran, MD

The Blood and Marrow Transplant Group of Georgia

     Asad Bashey, MD, PhD
     Scott R. Solomon, MD
     Melhem Sohl, MD
     Kent Holland, MD

Date:Wednesday, November 28, 2018
Location: The Hyatt Lodge at McDonald's Campus

2815 Jorie Blvd, Oak Brook, IL 60523


5:30-6:15 pm- Exhibits/Sign-In

6:15 pm- Dinner/Opening Remarks

6:30 pm- Introduction of Case #1: Treating with triplets at relapse: management of cardiopulmonary toxicities
Presented by: Anjana Chandran, MD and Tulio Rodriguez, MD
Advocate Lutheran General Hospital

7:05 pm- 
Introduction of Case #2: Car T-cells in multiple myeloma
Presented by: Michael Bishop, MD and Benjamin Derman, MD
University of Chicago Medical Center

7:45 pm- Introduction of Case #3: Amyloidosis: when initial therapy is not enough
Presented by: Ami Badami, MD; Kevin Barton, MD; Patrick Hagen, MD
Loyola University Medical Center

8:30 pm- Closing Remarks/Q&A

Chicago Multiple Myeloma Rounds Committee 

Loyola University Medical Center: 
Kevin Barton, MD
      Patrick Hagen, MD

Advocate Lutheran General Hospital: 
Tulio Rodriguez, MD

Medical College of Wisconsin:
Binod Dhakal, MD
     Parameswaran Hari, MD

Rush University Medical Center:
Agne Paner, MD, (Program Chair) and Parameswaran Venugopal, MD

John H. Stroger, Jr Hospital of Cook County:
David Sumoza, MD    

University of Illinois at Chicago Medical Center:
    Pritesh Patel, MD

University of Chicago Medical Center:
Michael Bishop, MD

Date: Tuesday, December 11, 2018
Location: Tampa Marriott Waterside Hotel and Marina
700 S. Florida Ave, Tampa, FL 33602


5:30 pm: Exhibits/Registration/Dinner

6:15 pm: Opening Remarks

   Florida Multiple Myeloma Rounds Committee

6:30 pm: Introduction of Case #1:

   Rachid Baz, MD: Moffitt Cancer Center

7:10 pm: Introduction of Case #2:
Melissa Alsina, MD: Moffitt Cancer Center

7:50 pm: Introduction of Case #3:
Ken Shain, MD: Moffitt Cancer Center

8:30 pm: Closing Remarks/Discussion

Florida Multiple Myeloma Rounds Committee

Moffitt Cancer Center:
    Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD

Date:Wednesday, November 28, 2018
Location: The Hilton Indianapolis Hotel and Suites

120 W. Market St, Indianapolis, Indiana 46204


5:30-6:15 pm- Exhibits/Sign-In

6:15 pm- Dinner

6:30 pm- Opening Remarks 

6:45 pm- Introduction of Case #1: Abstracts from ASH 2018: What are the Hot Topics in Multiple Myeloma
 Presented by:  Attaya Suvannasankha, MD
    Indiana University School of Medicine

7:30 pm- Introduction of Case #2: Treating with triplets at relapse: management of cardiopulmonary toxicities
Presented by: Anjana Chandran and Tulio Rodriguez, MD- Advocate Lutheran General Hospital 

8:05 pm- Introduction of Case #3: Car T-cells in multiple myeloma
 Presented via Simulcast:  Michael Bishop, MD and Benjamin Derman, MD
University of Chicago Medical Center

8:30 pm- Closing Remarks/Q&A


NYC/NJ Multiple Myeloma Rounds Committee

Memorial Sloan Kettering Cancer Center: 
       Ola Landgren, MD (Program Chair)

Columbia University Medical Center:
       Suzanne Lentzsch, MD

Hackensack Medical Center: 
        David Siegel, MD, Noa Biran, MD, David Vesole, MD

Memorial Sloan Kettering Cancer Center: 
        Neha S. Korde, MD

Mount Sinai Hospital: 
       Sundar Jagannath, MD, Joshua Richter, MD, Deepu Madduri, MD

Weill Cornell Medical Center: 

       Ruben Niesvizky, MD, Roger N. Pearse, MD, Adriana Rossi, MD, Cara Rosenbaum, MD

Date: Thursday, November 15
Renaissance Seattle Hotel
                  515 Madison St, Seattle, WA 98104


5:30 pm- Exhibits/Registration

6:15 pm- Dinner

6:30 pm- Opening Remarks

6:40pm- Introduction of Case #1: Management of Ultra-High-Risk Myeloma/Plasma Cell Leukemia
Presented by: Pam Becker, MD

Seattle Cancer Care Alliance

7:15pm- Introduction of Case #2: Renal Failure in Newly Diagnosed Myeloma
Presented by: Ali Khaki, MD and Bilal Malik, MD

University of Washington Medical Center

8:00pm- Group Discussion/Q&A

Seattle Multiple Myeloma Rounds Committee 

Swedish Cancer Institute
     William Bensinger, MD (CO-CHAIR)

Seattle Cancer Care Alliance/University of Washington
      Edward Libby, MD (CO-CHAIR)

Fred Hutchinson Cancer Center: 
     Damian Green, MD

Swedish Cancer Institute: 
      Ami Batchelder, PA-C

VA Puget Sound Health Care system/University of Washington Medical Center    
     Thomas Chauncey, MD

The Multiple Myeloma Rounds program is proudly endorsed by:
The Leukemia Foundation
The Amyloidosis Foundation

LRF Logo high res    logo colors 04 text at bottomsmall

If your company is interested in exhibiting at any of these events, please contact us at:

E-mail: [email protected]

Phone: 1-866-607-4333

Your Information

Your Name*
Your Email:*
Kosher Meal Request? (not available at all venues):*
How did you hear about this program?: *

Categories: Symposia

Don't have an account yet? Register Now!

Sign in to your account